These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12600417)

  • 41. Chemosensitivity testing of paclitaxel versus docetaxel in human gynecological carcinomas: a comparison with carboplatin.
    Koshiyama M; Kinezaki M; Uchida T; Sumitomo M
    Anticancer Res; 2006; 26(5B):3655-9. PubMed ID: 17094381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endometrial cancer cell lines are sensitive to paclitaxel.
    Rantanen V; Grénman S; Kulmala J; Grénman R
    Anticancer Res; 1996; 16(1):475-9. PubMed ID: 8615657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current status of chemotherapy in gynecologic cancer.
    Tropé C; Kristensen G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
    [No Abstract]   [Full Text] [Related]  

  • 44. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
    Muggia FM
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.
    Cree IA; Kurbacher CM; Lamont A; Hindley AC; Love S;
    Anticancer Drugs; 2007 Oct; 18(9):1093-101. PubMed ID: 17704660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay.
    Kirkpatrick DL; Duke M; Goh TS
    Leuk Res; 1990; 14(5):459-66. PubMed ID: 2345469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Chemosensitivity test for thyroid cancer by in vitro MTT assay].
    Sasaki F; Ishimura H; Takada N; Uchino J
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1777-81. PubMed ID: 7574809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of a CB17 scid mouse model and the tetrazolium-dye assay using human haematological tumour cell lines.
    Cattan AR; Maung ZT
    Cancer Chemother Pharmacol; 1996; 38(6):548-52. PubMed ID: 8823497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting nedaplatin sensitivity of cervical cancer using the histoculture drug response assay.
    Kato R; Hasegawa K; Achiwa Y; Okamoto H; Torii Y; Oe S; Udagawa Y
    Eur J Gynaecol Oncol; 2011; 32(4):381-6. PubMed ID: 21941957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sensitivity to cisplatin determined by the histoculture drug response assay and clinical response of endometrial cancer.
    Kanasugi M; Aoki D; Suzuki N; Susumu N; Nakata S; Horiuchi M; Udagawa Y; Nozawa S
    Int J Gynecol Cancer; 2006; 16(1):409-15. PubMed ID: 16445667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro chemosensitivity test for human genitourinary tumors using collagen gel matrix.
    Uchibayashi T; Egawa M; Hisazumi H; Hasegawa T; Tanaka T; Sasaki T
    Eur Urol; 1993; 24(2):267-70. PubMed ID: 7690707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotherapeutic drug sensitivity of primary cultures of epithelial ovarian cancer cells from patients in relation to tumour characteristics and therapeutic outcome.
    von Heideman A; Tholander B; Grundmark B; Cajander S; Gerdin E; Holm L; Axelsson A; Rosenberg P; Mahteme H; Daniel E; Larsson R; Nygren P
    Acta Oncol; 2014 Feb; 53(2):242-50. PubMed ID: 23713890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Placental leucine aminopeptidase (P-LAP) expression is associated with chemosensitivity in human endometrial carcinoma.
    Shibata K; Kikkawa F; Kondo C; Mizokami Y; Kajiyama H; Ino K; Nomura S; Mizutani S
    Gynecol Oncol; 2004 Nov; 95(2):307-13. PubMed ID: 15491750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy for gynecologic malignancies.
    Vermorken JB; Hoekman K
    Curr Opin Oncol; 1995 Sep; 7(5):457-65. PubMed ID: 8541392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay.
    Yamaue H; Tanimura H; Nakamori M; Noguchi K; Iwahashi M; Tani M; Hotta T; Murakami K; Ishimoto K
    Dis Colon Rectum; 1996 Apr; 39(4):416-22. PubMed ID: 8878502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nuclear localisation of glutathione S-transferase pi is an evaluation factor for drug resistance in gynaecological cancers.
    Soh Y; Goto S; Kitajima M; Moriyama S; Kotera K; Nakayama T; Nakajima H; Kondo T; Ishimaru T
    Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):264-70. PubMed ID: 15997922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
    Chen W; Zhou X; Xu Q; Guo W; Lin L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):404-7. PubMed ID: 12641948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Establishment of cisplatin-resistant human endometrial cancer cell line and the study of its resistant mechanisms].
    Xu QY; Chen YH; Zhao LJ; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):533-7. PubMed ID: 22041447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of an in vitro chemo-radiation response assay for cervical carcinoma.
    Monk BJ; Burger RA; Parker R; Radany EH; Redpath L; Fruehauf JP
    Gynecol Oncol; 2002 Nov; 87(2):193-9. PubMed ID: 12477451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.